Pulse Biosciences, Inc. (PLSE) Misses Q2 EPS by 4c
Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q2 EPS of ($0.55), $0.04 worse than the analyst estimate of ($0.51).Recent Corporate DevelopmentsThe ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
